S&P raises Winchester Hospital’s bond rating to ‘A’

S&P has raised its rating on $70.7 million of series 2010H bonds issued on behalf of Winchester (Mass.) Hospital, a subsidiary of Lahey Health System, to “A” from “A-.”

Advertisement

“The upgrade of Winchester reflects its position as a highly strategic subsidiary of LHS given its importance to LHS’ strategy to shift patients to the lowest cost setting, its geographic significance to LHS’ market, its solid profitability, equal board representation, and management’s stated desire to move Winchester’s debt into the LHS obligated group,” said S&P analyst Cynthia Keller.

The hospital’s rating outlook is stable.

More articles on healthcare finance:

3 negative, 19 positive hospital rating actions in past month
Hospital closure sparks interest in Kansas Medicaid expansion
Carolinas HealthCare expansion efforts pay off in first half of 2015

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.